HOME › Press Releases › Patient Monitoring Device/Equipment/System Market worth 24,762 Million USD by 2020
Patient Monitoring Device/Equipment/System Market worth 24,762 Million USD by 2020
The report “Patient Monitoring Device/Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Ultiparameter, Remote, Weight, Temperature), End-User (Hospitals, Home) - Global Forecast to 2020”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global patient monitoring devices market along with the estimates and forecasts of the revenue and share analysis.
Browse 160 market data Tables and 87 Figures spread through 204 Pages and in-depth TOC on "Patient Monitoring Device/Equipment/System Market by Product (Blood Glucose, EEG, ECG, Capnography, Spirometer, Sleep Apnea, Pulse Oximeter, Fetal Doppler, Ultiparameter, Remote, Weight, Temperature), End-User (Hospitals, Home) - Global Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global patient monitoring devices market will reach USD 24,762 Million by 2020 growing at a CAGR of 5.6% during the forecast period (2015–2020).
The driving factors of the patient monitoring market include growing population size of the elderly, rising incidences of unhealthy lifestyle, and technological developments like portability of equipment. The cardiac monitors segment had the largest share in 2015 of the total patient monitoring devices market, whereas neuromonitoring devices segment will be the fastest growing segment by 2020.
On the basis of products, patient monitoring devices market is segregated into nine main segments, namely, hemodynamic, neurology, cardiac, respiratory, fetal and neonatal, multiparameter, remote patient monitors, temperature, and weight management monitors. The respiratory monitors segment is also expected to grow at a high pace in the forecast period. This growth can be attributed to the rising incidences of obstructive sleep apnea and the rising alternate uses of capnographs. The remote patient monitoring (RPM) devices segment is expected to grow at a fast pace majorly driven by government regulations to control the rising healthcare costs. The technological innovations and developments of products are contributing to the market growth of RPM devices.
North America accounted for the highest share in 2015 and is poised to grow from 2015 to 2020. The major growth factors contributing to the growth of the North America market are the aging population and lifestyle diseases that are further adding to the overall prevalence of chronic diseases. Europe was the second leading contributor to the patient monitoring devices market in 2015. However, the growth of this region is expected to be sluggish in the forecast period and is estimated to grow at a lower CAGR, due to factors such as uneven reimbursement policies, declining birth rates, and reduced number of beds in hospitals.
APAC is the most promising region for patient monitoring devices in the coming five years. It is expected to grow at a higher CAGR over the forecast period. High population base and improved purchasing power of patients will be the major drivers of this market. Moreover, the economic instability in the western countries enables the companies to focus on the APAC region in order to meet their revenue targets.
The key players in the patient monitoring devices market are Abbott Laboratories (U.S), GE Healthcare (U.K.), Nihon Kohden (Japan), Omron Healthcare (Japan), Philips Healthcare (Netherlands) and Roche Diagnostics Limited (Switzerland).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India